US 8940688
Fluorinated tripeptide HCV serine protease inhibitors
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8940688 (Fluorinated tripeptide HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00